Financing Global Health 2017 is the ninth edition of IHME’s annual series on global health spending and health financing. In addition to describing the trends in development assistance for health (DAH) and domestic government, prepaid private, and out-of-pocket health spending, this year’s report features a deep dive into financing focused on HIV/AIDS and estimates health care spending and potential gains in UHC service coverage through 2040.
Portugal: The Nation’s Health 1990–2016 explores the progress Portugal has experienced over the last 26 years, in terms of health, well-being, and development, and the new challenges it faces as its population grows and ages.
This report draws from the Access, Bottlenecks, Costs, and Equity (ABCE) project in Gujarat, India, part of a multi-pronged and multi-country research collaboration focused on understanding what drives and hinders health service provision.
This report draws from the Access, Bottlenecks, Costs, and Equity (ABCE) project in Madhya Pradesh, India, part of a multi-pronged and multi-country research collaboration focused on understanding what drives and hinders health service provision.
This report draws from the Access, Bottlenecks, Costs, and Equity (ABCE) project in Odisha, India, part of a multi-pronged and multi-country research collaboration focused on understanding what drives and hinders health service provision.
This report draws from the Access, Bottlenecks, Costs, and Equity (ABCE) project in Tamil Nadu, India, part of a multi-pronged and multi-country research collaboration focused on understanding what drives and hinders health service provision.
This report draws from the Access, Bottlenecks, Costs, and Equity (ABCE) project in Andhra Pradesh and Telangana, India, part of a multi-pronged and multi-country research collaboration focused on understanding what drives and hinders health service provision.
With almost one-fifth of the world’s population living in India, the health status and the drivers of health loss are expected to vary between different parts of the country and between the states. Accordingly, effective efforts to improve population health in each state require systematic knowledge of the local health status and trends. While state-level trends for some important health indicators have been available in India, a comprehensive assessment of the diseases causing the most premature deaths and disability in each state, the risk factors responsible for this burden, and their time trends have not been available in a single standardised framework. Based on intense work over two years, this report describes the distribution and trends of diseases and risk factors for every state of India from 1990 to 2016.
To commemorate the 20th Anniversary of the Global Burden of Disease (GBD) study, this magazine highlights the history, progress, collaboration, and impact of GBD.
This brief provides an overview of cross-country findings for the 2013-2016 Full Country Evaluations (FCE). The FCE is a prospective study covering the period 2013–2016 with the aim of understanding and quantifying the barriers to and drivers of immunization program improvement, with emphasis on the contribution of Gavi, the Vaccine Alliance in four countries: Bangladesh, Mozambique, Uganda, and Zambia.
This brief provides an overview of findings in Bangladesh for the 2013-2016 Full Country Evaluations (FCE). The FCE is a prospective study covering the period 2013–2016 with the aim of understanding and quantifying the barriers to and drivers of immunization program improvement.
This brief provides an overview of findings in Mozambique for the 2013-2016 Full Country Evaluations (FCE). The FCE is a prospective study covering the period 2013–2016 with the aim of understanding and quantifying the barriers to and drivers of immunization program improvement.
This brief provides an overview of findings in Uganda for the 2013-2016 Full Country Evaluations (FCE). The FCE is a prospective study covering the period 2013–2016 with the aim of understanding and quantifying the barriers to and drivers of immunization program improvement.
This brief provides an overview of findings Zambia for the 2013-2016 Full Country Evaluations (FCE). The FCE is a prospective study covering the period 2013–2016 with the aim of understanding and quantifying the barriers to and drivers of immunization program improvement.
This report presents findings for Bangladesh from the 2016 Gavi Full Country Evaluations Annual Dissemination Report. The Gavi Full Country Evaluations (FCE) is a prospective study covering the period 2013–2016 with the aim of understanding and quantifying the barriers to and drivers of immunization program improvement, with emphasis on the contribution of Gavi, the Vaccine Alliance in four countries: Bangladesh, Mozambique, Uganda, and Zambia.
This report presents findings for Mozambique from the 2016 Gavi Full Country Evaluations Annual Dissemination Report. The Gavi Full Country Evaluations (FCE) is a prospective study covering the period 2013–2016 with the aim of understanding and quantifying the barriers to and drivers of immunization program improvement, with emphasis on the contribution of Gavi, the Vaccine Alliance in four countries: Bangladesh, Mozambique, Uganda, and Zambia.
This report presents findings for Zambia from the 2016 Gavi Full Country Evaluations Annual Dissemination Report. The Gavi Full Country Evaluations (FCE) is a prospective study covering the period 2013–2016 with the aim of understanding and quantifying the barriers to and drivers of immunization program improvement, with emphasis on the contribution of Gavi, the Vaccine Alliance in four countries: Bangladesh, Mozambique, Uganda, and Zambia.
This report presents findings for Uganda from the 2016 Gavi Full Country Evaluations Annual Dissemination Report. The Gavi Full Country Evaluations (FCE) is a prospective study covering the period 2013–2016 with the aim of understanding and quantifying the barriers to and drivers of immunization program improvement, with emphasis on the contribution of Gavi, the Vaccine Alliance in four countries: Bangladesh, Mozambique, Uganda, and Zambia.
This report presents cross-country findings from the 2016 Gavi Full Country Evaluations Annual Dissemination Report. The Gavi Full Country Evaluations (FCE) is a prospective study covering the period 2013–2016 with the aim of understanding and quantifying the barriers to and drivers of immunization program improvement, with emphasis on the contribution of Gavi, the Vaccine Alliance in four countries: Bangladesh, Mozambique, Uganda, and Zambia.
Financing Global Health 2016 is the eighth edition of IHME’s annual series on global health spending and health financing. In addition to describing the trends in development assistance for health (DAH), this year’s report features an expanded discussion of domestic spending across low-, middle-, and high-income countries to describe the context in which DAH operates, identify health financing gaps, and support the pursuit of universal health coverage.
Disparities on the Path to Universal Health Coverage presents a retrospective and prospective look at global trends in health financing, with a focus on understanding trends related to economic development and development assistance for health. This report is based on the Financing Global Health (FGH) 2016 study, a yearly effort conducted by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington in Seattle.
The GBD 2015 study shows that, from 1990 to 2015, the world as a whole has been undergoing an epidemiological transition. The nature of that transition is discussed in this report.
Namibia: State of the Nation’s Health explores the progress Namibia has experienced over the last two decades and the new challenges it faces as its population grows and ages.
The Global Burden of Disease: Generating Evidence, Guiding Policy in Kenya explores health progress in Kenya over the past 23 years and examines the challenges the country faces as its population grows and the landscape of its health shifts.
